What treatment did you choose for Stage IIB prostate cancer?
Community Member
5 days agoI was recently diagnosed with Stage IIB unfavorable intermediate-risk prostate cancer. My oncologist explained that I have several treatment options available, including different types of radiation therapy (external beam or internal seeds) combined with hormone therapy, surgical removal of the prostate with lymph node examination, or careful monitoring. They mentioned that the best approach will depend on my overall health, preferences, and specific cancer characteristics. I'd love to connect with others who have faced similar treatment decisions for Stage IIB prostate cancer. • What factors helped you decide between radiation, surgery, or monitoring? • What do you wish you had known when weighing these treatment options?
Community Member
5 days agoFacing a Stage IIB prostate cancer diagnosis and weighing treatment options can feel overwhelming, but connecting with others who've navigated similar decisions can provide valuable insights and support. Many community members have shared their experiences with radiation therapy, surgery, and active surveillance, discussing factors like their age, overall health, potential side effects, and personal priorities that influenced their choices. This community is a great place to learn from others' journeys and find the support needed during this important decision-making process.
New to the community?
Create an account to connect with others navigating cancer.
Related Questions
- What helped you choose between active surveillance and treatment for low-risk prostate cancer?
- What's the difference between active surveillance and observation for low-risk prostate cancer?
- Should I choose surgery or radiation for Gleason 7 prostate cancer?
- What are the best treatment options for Gleason 4+3 prostate cancer?
- How can I support my sons after prostate cancer diagnosis at 89?
- Rising PSA and Prostate Cancer Diagnosis at 65
- What treatment did you choose for Stage IIB prostate cancer?
© 2026 Outcomes4Me Inc. All rights reserved.